七氟烷与丙泊酚全静脉麻醉在减重手术中的术中免疫调节作用(OBESITA试验):一项随机对照先导试验的研究方案
OBESITA试验为前瞻性、非盲、单中心、随机对照先导试验,计划纳入48例体重指数≥35 kg/m²的腹腔镜减重手术患者,1:1随机接受七氟烷吸入麻醉或丙泊酚全静脉麻醉,主要终点为两组血浆白细胞介素-6水平的差异,并评估其他促炎与抗炎细胞因子、中性粒细胞趋化、巨噬细胞分化、吞噬作用及术中术后并发症。
要点
- OBESITA试验拟纳入48例体重指数≥35 kg/m²的腹腔镜减重手术患者。
- 患者1:1随机接受七氟烷吸入麻醉或丙泊酚全静脉麻醉。
- 主要终点为两组血浆白细胞介素-6水平的差异。
核心结论
- 作者假设七氟烷麻醉较丙泊酚麻醉产生更弱的促炎反应,循环白细胞介素-6及其他促炎介质水平更低,脂肪组织中巨噬细胞向M2表型分化增加。
研究设计与样本
- OBESITA试验为前瞻性、非盲、单中心、随机对照临床先导试验,计划纳入48例体重指数≥35 kg/m²、拟行袖状胃切除或Roux-en-Y胃旁路术的腹腔镜减重手术患者,1:1随机接受七氟烷吸入全身麻醉或丙泊酚全静脉麻醉(TIVA)。
主要发现
- 主要终点为两组血浆白细胞介素-6水平的差异,血样于麻醉诱导前(基线)、麻醉诱导后即刻及气管拔管前采集。
- 还将评估其他促炎与抗炎细胞因子水平、中性粒细胞趋化、巨噬细胞分化、吞噬作用及术中术后并发症的发生情况。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Obesity is associated with a chronic systemic inflammatory process. Volatile or intravenous anesthetic agents may modulate immune function, and may do so differentially in obesity. However, no study has evaluated whether these potential immunomodulatory effects differ according to type of anesthesia in obese patients undergoing laparoscopic bariatric surgery. METHODS/DESIGN: The OBESITA trial is a prospective, nonblinded, single-center, randomized, controlled clinical pilot trial. The trial will include 48 patients with a body mass index ≥ 35 kg/m2, scheduled for laparoscopic bariatric surgery using sleeve or a Roux-en-Y gastric bypass technique, who will be allocated 1:1 to undergo general inhalational anesthesia with sevoflurane or total intravenous anesthesia (TIVA) with propofol. The primary endpoint is the difference in plasma interleukin (IL)-6 levels when comparing the two anesthetic agents. Blood samples will be collected prior to anesthesia induction (baseline), immediately after anesthetic induction, and before endotracheal extubation. Levels of other proinflammatory and anti-inflammatory cytokines, neutrophil chemotaxis, macrophage differentiation, phagocytosis, and occurrence of intraoperative and postoperative complications will also be evaluated. DISCUSSION: To our knowledge, this is the first randomized clinical trial designed to compare the effects of two different anesthetics on immunomodulation in obese patients undergoing laparoscopic bariatric surgery. Our hypothesis is that anesthesia with sevoflurane will result in a weaker proinflammatory response compared to anesthesia with propofol, with lower circulating levels of IL-6 and other proinflammatory mediators, and increased macrophage differentiation into the M2 phenotype in adipose tissue. TRIAL REGISTRATION: Registro Brasileiro de Ensaios Clínicos, RBR-77kfj5 . Registered on 25 July 2018.
引用
- de Sousa GC, Cruz FF, Heil LB, et al. Intraoperative immunomodulatory effects of sevoflurane versus total intravenous anesthesia with propofol in bariatric surgery (the OBESITA trial): study protocol for a randomized controlled pilot trial. Trials. 2019. PMID: 31138279. doi:10.1186/s13063-019-3399-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。